Serveur d'exploration sur la maladie de Parkinson - Exploration (Accueil)

Index « Titre (en) » - entrée « neuroprotective »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
neuroprotection < neuroprotective < neuropsychiatric  Facettes :

List of bibliographic references indexed by neuroprotective

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000229 (2011) Yuen-Sum Lau [États-Unis] ; Gaurav Patki [États-Unis] ; Kaberi Das-Panja [États-Unis] ; Wei-Dong Le [États-Unis] ; S. Omar Ahmad [États-Unis]Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson’s disease with moderate neurodegeneration
000230 (2011) Lucia Frau [Italie] ; Franco Borsini [Italie] ; Jadwiga Wardas [Pologne] ; Amit S. Khairnar [Italie] ; Nicoletta Schintu [Italie] ; Micaela Morelli [Italie]Neuroprotective and anti‐inflammatory effects of the adenosine A2A receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease
000416 (2011) Anthony E. Lang [Canada]A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials
000630 (2010) Xiao-Qing Tang [République populaire de Chine] ; Yu-Juan Li ; Jing Zhao ; Xing-Tian Shen ; Chun-Tao Yang ; Li-Li Fan ; Bi Hu ; Yuan-Jian Li ; Duan-Fan Liao [République populaire de Chine]Neuroprotective effect of asymmetric dimethylarginine against 1‐methyl‐4‐phenylpyridinium ion‐induced damage in PC12 cells
000A18 (2009) You-Joung Kim [Corée du Sud] ; Hyun-Jung Park [Corée du Sud] ; Gwang Lee [Corée du Sud] ; Oh Young Bang [Corée du Sud] ; Young Hwan Ahn [Corée du Sud] ; Eunhye Joe [Corée du Sud] ; Hyun Ok Kim [Corée du Sud] ; Phil Hyu Lee [Corée du Sud]Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti‐inflammatory action
001003 (2007) Julie Deguil [France] ; David Jailloux [France] ; Guylène Page [France] ; Bernard Fauconneau [France] ; Jean-Luc Houeto [France] ; Michel Philippe [France] ; Jean-Marc Muller [France] ; Stéphanie Pain [France]Neuroprotective effects of pituitary adenylate cyclase–activating polypeptide (PACAP) in MPP+‐induced alteration of translational control in Neuro‐2a neuroblastoma cells
001004 (2007) Hyun Jung Park [Corée du Sud] ; Phil Hyu Lee [Corée du Sud] ; Young Whan Ahn [Corée du Sud] ; Yun Jung Choi [Corée du Sud] ; Gwang Lee [Corée du Sud] ; Da-Yong Lee [Corée du Sud] ; Eun S. Chung [Corée du Sud] ; Byung Kwan Jin [Corée du Sud]Neuroprotective effect of nicotine on dopaminergic neurons by anti‐inflammatory action
001220 (2006) Stephen B. Dunnett [Royaume-Uni] ; Anders Bjrklund [Suède]Prospects for new restorative and neuroprotective treatments in Parkinson's disease
001453 (2005) Orly Weinreb [Israël] ; Tamar Amit [Israël] ; Orit Bar-Am [Israël] ; Orly Chillag-Talmor [Israël] ; Moussa B. H. Youdim [Israël]Novel Neuroprotective Mechanism of Action of Rasagiline Is Associated with Its Propargyl Moiety: Interaction of Bcl‐2 Family Members with PKC Pathway
001458 (2005) C. Warren Olanow [États-Unis] ; Joseph Jankovic [États-Unis]Neuroprotective therapy in Parkinson's disease and motor complications: A search for a pathogenesis‐targeted, disease‐modifying strategy
001599 (2004) Bala V. Manyam [États-Unis] ; Muralikrishnan Dhanasekaran [États-Unis] ; Theodore A. Hare [États-Unis]Neuroprotective effects of the antiparkinson drug Mucuna pruriens
001A12 (2001) Gustavo A. Carvalho [Allemagne] ; Guido Nikkhah [Allemagne]Subthalamic Nucleus Lesions Are Neuroprotective against Terminal 6-OHDA-Induced Striatal Lesions and Restore Postural Balancing Reactions
001B58 (2000) A. Björklund [Suède] ; D. Kirik [Suède] ; C. Rosenblad [Danemark] ; B. Georgievska [Suède] ; C. Lundberg [Suède] ; R. J. Mandel [États-Unis]Towards a neuroprotective gene therapy for Parkinson’s disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model
001F14 (1998) ShoulsonDATATOP: A decade of neuroprotective inquiry
002009 (1997) Anumantha G. Kanthasamy [États-Unis] ; Arthi Kanthasamy [États-Unis] ; Rae R. Matsumoto [États-Unis] ; Toan Q. Vu [États-Unis] ; Daniel D. Truong [États-Unis]Neuroprotective effects of the strychnine-insensitive glycine site NMDA antagonist ( R )-HA-966 in an experimental model of Parkinson's disease
002010 (1997) William C. KollerNeuroprotective Therapy for Parkinson's Disease
002529 (1993) G. Bernocchi [Italie] ; G. Gerzeli [Italie] ; E. Scherini [Italie] ; C. Vignola [Italie]Neuroprotective effects of α-dihydroergocryptine against damages in the substantia nigra caused by severe treatment with 1-methyl-4-phenyl-1,3,3,6-tetrahydropyridine
002D89 (????) Ann K. Wright ; Marianela Garcia-Munoz ; Gordon W. ArbuthnottSlowly Progressive Dopamine Cell Loss - A Model on which to Test Neuroprotective Strategies for Parkinson's Disease?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "neuroprotective" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "neuroprotective" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    neuroprotective
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024